The use of tumor necrosis factor neutralization strategies in rheumatologic disorders other than rheumatoid arthritis in Lebanon

Seminars in Arthritis and Rheumatism

Volumn 33, Issue 6, 2004, Pages 422-423

  Uthman, Imad ^a   Mroueh, Kamel ^a   Arayssi, Thuraya ^a   Nasr, Fuad ^a   Masri, Abdul Fattah ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ANTIRHEUMATIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHOTREXATE; PREDNISONE; STEROID; TUMOR NECROSIS FACTOR;

ANKYLOSING SPONDYLITIS; AORTA ARCH SYNDROME; BEHCET DISEASE; COGAN SYNDROME; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LEBANON; LETTER; MIXED CONNECTIVE TISSUE DISEASE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; CHILD; FEMALE; HUMANS; LEBANON; MALE; MIDDLE AGED; RHEUMATIC DISEASES; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3042803285     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2003.12.005     Document Type: Letter

References (2)

1. Stokes D.G, Kremer J.M. Potential of tumor necrosis factor neutralization strategies in rheumatologic disorders other than rheumatoid arthritis. Semin Arthritis Rheum. 33:2003;1-18
2. Uthman I, Kassak K, Sanjakdar R, Mendelek V, Masri A.F, Nasr F.W. Letter from Lebanon. Br J Rheumatol. 36:1997;806-807